| Datum | Källa | Rubrik | Typ | Alternativ |
|---|---|---|---|---|
| 2024-06-04 | OssDsign | OssDsign AB: OssDsign publicerar Årsredovisning 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-06-04 | OssDsign | OssDsign AB: OssDsign publishes Annual Report 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-30 | OssDsign | OssDsign AB: 5,000 patients treated with OssDsign Catalyst® in the U.S. | Pressreleaser | Ladda ner | Visa Stäng |
|
Pressreleaser |
OssDsign AB: 5,000 patients treated with OssDsign Catalyst® in the U.S.The continuous and rapid increase in treated patients is a strong testament to how well OssDsign Catalyst has been received in the U.S. market since its launch in August 2021. ”With 5,000 patients treated, the use of OssDsign Catalyst is not just growing, it’s accelerating. This is a significant leap from the earlier announcements of 2,000 patients treated in September 2023 and 1,000 patients in May 2023, demonstrating the rapid pace with which we are building our orthobiologics business,” said Morten Henneveld, CEO of OssDsign. OssDsign Catalyst is a nanosynthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries. The graft is composed of a proprietary nanocrystalline structure which is resorbed and replaced by new and healthy bone tissue in the body. 12-month results from the clinical study TOP FUSION, published in the peer-reviewed journal Biomedical Journal of Scientific & Technical Research, show a 93 % spinal fusion rate as well as improvements in quality of life and pain following surgery with OssDsign Catalyst. |
||||
| 2024-05-30 | OssDsign | OssDsign AB: 5 000 patienter behandlade med OssDsign Catalyst® i USA | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-24 | OssDsign | OssDsign AB: NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN OSSDSIGN AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-24 | OssDsign | OssDsign AB: KALLELSE TILL ÅRSSTÄMMA I OSSDSIGN AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-16 | OssDsign | OssDsign AB: Change of financial calendar | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-16 | OssDsign | OssDsign AB: Ändring av finansiell kalender | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Redeye | Redeye: OssDsign Q1 - An accelerating turnaround | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-15 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: A new beginning – Q1 review | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-05-14 | OssDsign | OssDsign AB (publ) publishes Q1 2024 interim report | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-05-14 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för första kvartalet 2024 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-29 | OssDsign | OssDsign AB: OssDsign får tillgång till 100 nya sjukhus inom U.S. Veteran Affairs med sitt syntetiska bengraft | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-29 | OssDsign | OssDsign AB: OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-11 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Another quarter of triple-digit Catalyst growth expected | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-04-02 | OssDsign | OssDsign AB: OssDsign awarded long-term agreement with Premier, Inc. | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-04-02 | OssDsign | OssDsign AB: OssDsign tecknar flerårigt avtal med Premier, Inc. | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-03-07 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Update after HC seminar and news in the spinal fusion market | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-29 | OssDsign | OssDsign AB: OssDsign utser Tom Buckland till Chief Technical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-29 | OssDsign | OssDsign AB: OssDsign appoints Tom Buckland as Chief Technical Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-07 | Redeye | Redeye: Q4 - Sales will go up, and costs will go down | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-07 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Restructuring completed, focus on 2024 | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-02-06 | OssDsign | OssDsign AB (publ) publishes year-end report 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-02-06 | OssDsign | OssDsign AB (publ) publicerar bokslutskommuniké 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-29 | Carnegie Commissioned Research | Carnegie Commissioned Research: OssDsign: Right time to fuse the spine | Pressreleaser | Visa Stäng |
|
|
||||
| 2024-01-24 | OssDsign | OssDsign AB: 12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-24 | OssDsign | OssDsign AB: Tolvmånadersdata från klinisk studie med OssDsign Catalyst™ publicerad i Biomedical Journal of Scientific & Technical Research | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-09 | OssDsign | OssDsign AB: OssDsign reports exceptional data from the clinical study TOP FUSION | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2024-01-09 | OssDsign | OssDsign AB: OssDsign rapporterar exceptionella data från den kliniska studien TOP FUSION | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-07 | Redeye | Redeye: OssDsign - Higher-than-expected Q4 preliminary sales | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-06 | OssDsign | OssDsign AB: OssDsign's revenues for the fourth quarter of 2023 are expected to exceed market estimates | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-12-06 | OssDsign | OssDsign AB: OssDsigns intäkter för det fjärde kvartalet 2023 förväntas överstiga marknadens förväntningar | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: SEB Venture Capital has sold its holding in OssDsign | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: SEB Venture Capital har avyttrat sitt innehav i OssDsign | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: OssDsign byter Certified Adviser till Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-30 | OssDsign | OssDsign AB: OssDsign changes Certified Adviser to Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-23 | Penser Access | Penser Access: Intervju med OssDsign - Erik Penser Bank - 23 november 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-22 | Penser Access | Penser Access: Benhård tillväxt - OssDsign | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-11-22 | Redeye | Redeye: OssDsign Q3 - Catalyst is growing as expected | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-21 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för tredje kvartalet 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-11-21 | OssDsign | OssDsign AB (publ) publishes Q3 2023 Interim Report | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-16 | OssDsign | Extra bolagsstämma har hållits i OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-16 | OssDsign | Extraordinary General Meeting held in OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-11 | OssDsign | OssDsign AB: OssDsign Catalyst blir allmänt tillgänglig för alla militära vårdinrättningar i USA via ECAT | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-10-09 | Penser Access | Penser Access: Intervju med OssDsign - Erik Penser Bank - 9 oktober 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-28 | Redeye | Redeye: OssDsign - Fully funded and fully focused | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-28 | Penser Access | Penser Access: Strategiskifte och nyemission - OssDsign | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-09-27 | OssDsign | Notice to attend the extraordinary general meeting in OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-27 | OssDsign | Kallelse till extra bolagsstämma i OssDsign AB | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign has carried out a directed share issue of approximately SEK 150 million | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign har genomfört en riktad nyemission av aktier om cirka 150 miljoner kronor | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign explores the conditions to carry out a directed share issue | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign utreder förutsättningarna att genomföra en riktad nyemission av aktier | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign announces strategic shift to become a pure play orthobiologics company | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-26 | OssDsign | OssDsign AB: OssDsign genomför strategiskifte för att bli ett renodlat ortobiologiföretag | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-18 | OssDsign | OssDsign AB: OssDsign® Catalyst får utökat marknadsgodkännande från FDA för betydande ny indikation för användning i ryggradsburar | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-09-13 | OssDsign | OssDsign AB: 2 000 patienter behandlade med OssDsign[®] Catalyst i USA | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-30 | Penser Access | Penser Access: Intervju med OssDsign - Erik Penser Bank - 29 augusti 2023 | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-24 | Redeye | Redeye: OssDsign - Catalyst sets up for a turnaround | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-23 | Penser Access | Penser Access: 148% tillväxt i USA - OssDsign | Pressreleaser | Visa Stäng |
|
|
||||
| 2023-08-22 | OssDsign | OssDsign AB (publ) publicerar delårsrapport för andra kvartalet 2023 | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-22 | OssDsign | OssDsign AB (publ) publishes Q2 2023 Interim Report | Rapporter | Ladda ner | Visa Stäng |
|
|
||||
| 2023-08-16 | OssDsign | OssDsign AB: OssDsign har passerat 200 patienter i sitt prospektiva multicenterregister för ryggradsfusion, PROPEL | Pressreleaser | Ladda ner | Visa Stäng |
|
|
||||